Recap: Bicycle Therapeutics Q1 Earnings

Bicycle Therapeutics BCYC reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Bicycle Therapeutics missed estimated earnings by 36.76%, reporting an EPS of $-0.93 versus an estimate of $-0.68.

Revenue was up $2.05 million from the same period last year.

Last quarter the company missed on EPS by $0.02 which was followed by a 0.8% drop in the share price the next day.

Here's a look at Bicycle Therapeutics's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.61	-0.61	-0.71	-0.77
EPS Actual	-0.63	-0.59	-0.74	-0.73
Revenue Estimate	5.31M	4.43M	2.29M	2.02M
Revenue Actual	3.77M	4.33M	1.78M	1.81M

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Bicycle Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar